Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis

被引:210
作者
Lehuede, Camille [1 ,2 ]
Dupuy, Fanny [1 ,3 ]
Rabinovitch, Rebecca [1 ,4 ]
Jones, Russell G. [1 ,4 ]
Siegel, Peter M. [1 ,2 ,3 ,5 ,6 ]
机构
[1] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Biochem, Montreal, PQ, Canada
[4] McGill Univ, Dept Physiol, Montreal, PQ, Canada
[5] McGill Univ, Dept Oncol, Montreal, PQ, Canada
[6] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada
关键词
CANCER-ASSOCIATED FIBROBLASTS; BREAST-CANCER; PROSTATE-CANCER; AEROBIC GLYCOLYSIS; COLORECTAL-CANCER; ENERGY-METABOLISM; CELL-METABOLISM; STROMAL CELLS; FATTY-ACID; IN-VITRO;
D O I
10.1158/0008-5472.CAN-16-0266
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer cells must adapt their metabolism to meet the energetic and biosynthetic demands that accompany rapid growth of the primary tumor and colonization of distinct metastatic sites. Different stages of the metastatic cascade can also present distinct metabolic challenges to disseminating cancer cells. However, little is known regarding how changes in cellular metabolism, both within the cancer cell and the metastatic microenvironment, alter the ability of tumor cells to colonize and grow in distinct secondary sites. This review examines the concept of metabolic heterogeneity within the primary tumor, and how cancer cells are metabolically coupled with other cancer cells that comprise the tumor and cells within the tumor stroma. We examine how metabolic strategies, which are engaged by cancer cells in the primary site, change during the metastatic process. Finally, we discuss the metabolic adaptations that occur as cancer cells colonize foreign metastatic microenvironments and how cancer cells influence the metabolism of stromal cells at sites of metastasis. Through a discussion of these topics, it is clear that plasticity in tumor metabolic programs, which allows cancer cells to adapt and grow in hostile microenvironments, is emerging as an important variable that may change clinical approaches to managing metastatic disease. (C) 2016 AACR.
引用
收藏
页码:5201 / 5208
页数:8
相关论文
共 100 条
[1]   GLUT1 as a therapeutic target in hepatocellular carcinoma [J].
Amann, Thomas ;
Hellerbrand, Claus .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (12) :1411-1427
[2]  
Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12
[3]   Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival [J].
Baenke, Franziska ;
Dubuis, Sebastien ;
Brault, Charlene ;
Weigelt, Britta ;
Dankworth, Beatrice ;
Griffiths, Beatrice ;
Jiang, Ming ;
Mackay, Alan ;
Saunders, Becky ;
Spencer-Dene, Bradley ;
Ros, Susana ;
Stamp, Gordon ;
Reis-Filho, Jorge S. ;
Howell, Michael ;
Zamboni, Nicola ;
Schulze, Almut .
JOURNAL OF PATHOLOGY, 2015, 237 (02) :152-165
[4]   The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [J].
Ben Sahra, I. ;
Laurent, K. ;
Loubat, A. ;
Giorgetti-Peraldi, S. ;
Colosetti, P. ;
Auberger, P. ;
Tanti, J. F. ;
Le Marchand-Brustel, Y. ;
Bost, F. .
ONCOGENE, 2008, 27 (25) :3576-3586
[5]   The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells [J].
Ben Sahra, Issam ;
Tanti, Jean-Francois ;
Bost, Frederic .
AUTOPHAGY, 2010, 6 (05) :670-671
[6]   EMT-induced metabolite signature identifies poor clinical outcome [J].
Bhowmik, Salil Kumar ;
Ramirez-Pena, Esmeralda ;
Arnold, James Michael ;
Putluri, Vasanta ;
Sphyris, Nathalie ;
Michailidis, George ;
Putluri, Nagireddy ;
Ambs, Stefan ;
Sreekumar, Arun ;
Mani, Sendurai A. .
ONCOTARGET, 2015, 6 (40) :42651-42660
[7]   Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides [J].
Birsoy, Kivanc ;
Possemato, Richard ;
Lorbeer, Franziska K. ;
Bayraktar, Erol C. ;
Thiru, Prathapan ;
Yucel, Burcu ;
Wang, Tim ;
Chen, Walter W. ;
Clish, Clary B. ;
Sabatini, David M. .
NATURE, 2014, 508 (7494) :108-+
[8]   Metabolic Reprogramming of Immune Cells in Cancer Progression [J].
Biswas, Subhra K. .
IMMUNITY, 2015, 43 (03) :435-449
[9]   Ketones and lactate "fuel" tumor growth and metastasis Evidence that epithelial cancer cells use oxidative mitochondrial metabolism [J].
Bonuccelli, Gloria ;
Tsirigos, Aristotelis ;
Whitaker-Menezes, Diana ;
Pavlides, Stephanos ;
Pestell, Richard G. ;
Chiavarina, Barbara ;
Frank, Philippe G. ;
Flomenberg, Neal ;
Howell, Anthony ;
Martinez-Outschoorn, Ubaldo E. ;
Sotgia, Federica ;
Lisanti, Michael P. .
CELL CYCLE, 2010, 9 (17) :3506-3514
[10]   Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets [J].
Brastianos, Priscilla K. ;
Carter, Scott L. ;
Santagata, Sandro ;
Cahill, Daniel P. ;
Taylor-Weiner, Amaro ;
Jones, Robert T. ;
Van Allen, Eliezer M. ;
Lawrence, Michael S. ;
Horowitz, Peleg M. ;
Cibulskis, Kristian ;
Ligon, Keith L. ;
Tabernero, Josep ;
Seoane, Joan ;
Martinez-Saez, Elena ;
Curry, William T. ;
Dunn, Ian F. ;
Paek, Sun Ha ;
Park, Sung-Hye ;
McKenna, Aaron ;
Chevalier, Aaron ;
Rosenberg, Mara ;
Barker, Frederick G., II ;
Gill, Corey M. ;
Van Hummelen, Paul ;
Thorner, Aaron R. ;
Johnson, Bruce E. ;
Hoang, Mai P. ;
Choueiri, Toni K. ;
Signoretti, Sabina ;
Sougnez, Carrie ;
Rabin, Michael S. ;
Lin, Nancy U. ;
Winer, Eric P. ;
Stemmer-Rachamimov, Anat ;
Meyerson, Matthew ;
Garraway, Levi ;
Gabriel, Stacey ;
Lander, Eric S. ;
Beroukhim, Rameen ;
Batchelor, Tracy T. ;
Baselga, Jose ;
Louis, David N. ;
Getz, Gad ;
Hahn, William C. .
CANCER DISCOVERY, 2015, 5 (11) :1164-1177